Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Phase 2b/3 clinical trial for ABX-002

Next Previous
X
Search
Trial Profile

Phase 2b/3 clinical trial for ABX-002

Status: Planning
Phase of Trial: Phase II/III

Latest Information Update: 26 Jul 2024

Price : $35 *
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs ABX-002 (Primary)
  • Indications Adrenomyeloneuropathy
  • Focus Adverse reactions; Registrational
  • Sponsors Autobahn Therapeutics

    • Most Recent Events

    • 24 Jul 2024 According to an Autobahn Therapeutics media release, company today announced closing of an oversubscribed $100 million series C financing led by Newpath partners and proceeds from series C will be used to commence two Phase 2 clinical trials for ABX-002.
    • 09 Dec 2020 New trial record
    • 01 Dec 2020 According to an Autobahn Therapeutics media release, As part of the meeting, FDA aligned the companys proposal to conduct a single Phase 2b/3 adaptive trial to support a potential future registration of ABX-002.
Subscriber content

You need to be a logged in subscriber to view this content.

If your organization has a subscription then there are several options available to help you access AdisInsight, even while working remotely.

  • IP authentication when working within your organization’s network.
  • with username/password or try via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days.
  • Contact us at AsktheExpert.AdisInsight@springer.com for assistance.

If your organization does not have a subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Buy a PDF version of the profile.
  • Request a free trial
Back to top